Anhdao Thi Duong, OD
Optometrist · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Duong’s office at (408) 554-9830 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
Medicaid work
$4,389 in 2024
Medicaid paid $4,389 for 120 billed services this clinician did in 2024, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 96 | $4,043 |
| INTRM OPH EXAM NEW PATIENT | 24 | $346 |
| 2024 | 120 | 2 | 20 | $4,389 |
| 2023 | 30 | 1 | 17 | $0 |
| 2021 | 41 | 1 | 15 | $0 |
| 2020 | 56 | 2 | 17 | $0 |
| 2019 | 172 | 3 | 24 | $0 |
| 2018 | 237 | 3 | 30 | $0 |
See the largest Medicaid services in earlier years
2023
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 30 | $0 |
2021
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 41 | $0 |
2020
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 26 | $0 |
| DETERMINATION REFRACTIVE STATE | 30 | $0 |
2019
| INTRM OPH EXAM NEW PATIENT | 15 | $0 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 25 | $0 |
| DETERMINATION REFRACTIVE STATE | 132 | $0 |
2018
| INTRM OPH EXAM NEW PATIENT | 25 | $0 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 29 | $0 |
| DETERMINATION REFRACTIVE STATE | 183 | $0 |
Drugs they prescribed that Part D paid
$990
Pharmacies billed $990 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 27) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
19 generic and fewer than 11 brand-name prescriptions · $990 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 27 | 16 | 0% (0) | None | $990 |
| 2023 | 33 | 18 | 0% (0) | None | $910 |
| 2021 | 15 | None | 0% (0) | None | $804 |
| 2020 | 12 | None | 0% (0) | None | $784 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Latanoprost | 11 | $146 | $13 |
Money from drug and device companies
$196 in 2024
| 2024 | 3 | 3 | None | $196 |
| 2023 | 2 | 2 | None | $228 |
| 2020 | 1 | 1 | None | $137 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Glaukos | Ce-Marked Kxla System | $97 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $51 | 1 payment
|
| Dompe US | Oxervate | $48 | 1 payment
|
See all 3 published payments
| Oyster Point Pharma | Meals · 2024-01-17 | Tyrvaya | $51 |
| Dompe US | Meals · 2024-01-16 | Oxervate | $48 |
| Glaukos | Meals · 2024-01-09 | Ce-Marked Kxla System | $97 |
See earlier years (2023, 2020)
2023: $228
| Glaukos | None | $142 | 1 payment
|
| Alcon Vision | Dailies | $86 | 1 payment
|
2020: $137
| Johnson & Johnson Vision Care | Acuvue | $137 | 1 payment
|
Professional record
- NPI
- 1295877868
- Licence
- CA 11876T
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- 710 Lawrence Expy, Santa Clara, CA, 95051
- NPI first listed
- 2007-02-12
- NPI last updated
- 2023-02-16
- NPI record certified
- 2023-02-16
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.